These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31013189)

  • 1. Increased Incidence of Central Venous Catheter-Related Infection in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy.
    Waters PS; Smith AW; Fitzgerald E; Khan F; Moran BJ; Shields CJ; Lynch BL; O'Loughlin C; Lynch M; Mulsow J
    Surg Infect (Larchmt); 2019 Sep; 20(6):465-471. PubMed ID: 31013189
    [No Abstract]   [Full Text] [Related]  

  • 2. Does having a gastrectomy delay time to feeding and prolong hospital stay in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
    Shannon NB; Tan GHC; Chia CS; Soo KC; Teo MC
    Int J Hyperthermia; 2018 Aug; 34(5):518-523. PubMed ID: 28689443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
    Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, microbiology of venous catheter associated bloodstream infections--a prospective study from a tertiary care hospital.
    Kaur M; Gupta V; Gombar S; Chander J; Sahoo T
    Indian J Med Microbiol; 2015; 33(2):248-54. PubMed ID: 25865976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: A cost-utility analysis of a hospital's initial experience and reflections on the health care system.
    Naffouje SA; O'Donoghue C; Salti GI
    J Surg Oncol; 2016 Apr; 113(5):544-7. PubMed ID: 26750613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies.
    Dreznik Y; Hoffman A; Hamburger T; Ben-Yaacov A; Dux Y; Jacoby H; Berger Y; Nissan A; Gutman M
    Surgeon; 2018 Oct; 16(5):278-282. PubMed ID: 29429947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Khan S; Kelly KJ; Veerapong J; Lowy AM; Baumgartner JM
    Ann Surg Oncol; 2019 Jul; 26(7):2276-2284. PubMed ID: 31065960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained low incidence of central venous catheter-related infections over six years in a Swedish hospital with an active central venous catheter team.
    Hammarskjöld F; Berg S; Hanberger H; Taxbro K; Malmvall BE
    Am J Infect Control; 2014 Feb; 42(2):122-8. PubMed ID: 24485369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive Surgery and HIPEC in an Enhanced Recovery After Surgery Program: A Feasibility Study.
    Lu PW; Fields AC; Shabat G; Bleday R; Goldberg JE; Irani J; Stopfkuchen-Evans M; Melnitchouk N
    J Surg Res; 2020 Mar; 247():59-65. PubMed ID: 31767280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units.
    Gunst M; Matsushima K; Vanek S; Gunst R; Shafi S; Frankel H
    Surg Infect (Larchmt); 2011 Aug; 12(4):279-82. PubMed ID: 20629557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge.
    Bhagwandin SB; Naffouje S; Salti G
    J Surg Oncol; 2015 Mar; 111(3):324-7. PubMed ID: 25557653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis.
    Martin AS; Abbott DE; Hanseman D; Sussman JE; Kenkel A; Greiwe P; Saeed N; Ahmad SH; Sussman JJ; Ahmad SA
    Ann Surg Oncol; 2016 Jun; 23(6):1941-7. PubMed ID: 26842489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter-related infections in patients with acute type II intestinal failure admitted to a national centre: Incidence and outcomes.
    Bond A; Teubner A; Taylor M; Cawley C; Varden J; Abraham A; Chadwick PR; Soop M; Carlson GL; Lal S
    Clin Nutr; 2019 Aug; 38(4):1828-1832. PubMed ID: 30086999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious Complications after Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy.
    Arslan NC; Sokmen S; Avkan-Oguz V; Obuz F; Canda AE; Terzi C; Fuzun M
    Surg Infect (Larchmt); 2017; 18(2):157-163. PubMed ID: 27906610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Baumgartner JM; Kwong TG; Ma GL; Messer K; Kelly KJ; Lowy AM
    Ann Surg Oncol; 2016 May; 23(5):1609-17. PubMed ID: 26678406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies.
    Wong LCK; Wong JSM; Seo CJ; Soo KC; Ong CJ; Chia CS
    Int J Hyperthermia; 2022; 39(1):1195-1201. PubMed ID: 36096487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters.
    Simkens GA; van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH
    Ann Surg Oncol; 2016 Jan; 23(1):99-105. PubMed ID: 26148758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-home Discharge and Prolonged Length of Stay After Cytoreductive Surgery and HIPEC.
    Burguete D; Mokdad AA; Augustine MM; Minter R; Mansour JC; Choti MA; Polanco PM
    J Surg Res; 2019 Jan; 233():360-367. PubMed ID: 30502272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter-related infections: A Scandinavian observational study on the impact of a simple hygiene insertion bundle.
    Thorarinsdottir HR; Rockholt M; Klarin B; Broman M; Fraenkel CJ; Kander T
    Acta Anaesthesiol Scand; 2020 Feb; 64(2):224-231. PubMed ID: 31523802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.